Peter Feinberg, Director at Immuneering Corp (IMRX), bought 50,000 shares at $2.55 ($128K) on 2024-03-22, disclosed to the SEC on 2024-03-25.
Open-market purchase of $128k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 25,000 | $64K | 50.0% |
| 2 | $2.55 | 25,000 | $64K | 50.0% |
| Total | $2.55 avg | 50,000 | $128K | 100% |
| Filing → |
| IMRX | BUY | 2025-10-01 | $53K | — | Filing → |
| IMRX | BUY | 2025-09-30 | $36K | — | Filing → |
| IMRX | BUY | 2025-06-23 | $127K | — | Filing → |